Wang, X.; Lu, X.; Yan, D.; Zhou, Y.; Tan, X.
Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy. Int. J. Mol. Sci. 2022, 23, 7104.
https://doi.org/10.3390/ijms23137104
AMA Style
Wang X, Lu X, Yan D, Zhou Y, Tan X.
Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy. International Journal of Molecular Sciences. 2022; 23(13):7104.
https://doi.org/10.3390/ijms23137104
Chicago/Turabian Style
Wang, Xiang, Xing Lu, Daojing Yan, Yajun Zhou, and Xiangshi Tan.
2022. "Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy" International Journal of Molecular Sciences 23, no. 13: 7104.
https://doi.org/10.3390/ijms23137104
APA Style
Wang, X., Lu, X., Yan, D., Zhou, Y., & Tan, X.
(2022). Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy. International Journal of Molecular Sciences, 23(13), 7104.
https://doi.org/10.3390/ijms23137104